
Alicia Jenkins
Articles
-
Jan 16, 2025 |
jamanetwork.com | Jonathan Shaw |La Trobe |Alicia Jenkins
Diabetic Retinopathy—Another Possible Target for SGLT2 Inhibitors? Empagliflozin and the Risk of Retinopathy in Type 2 Diabetes Helen Tesfaye, PharmD, MSc; Julie M. Paik, MD, ScD, MPH; Miin Roh, MD, PhD; Phyo T. Htoo, MD, PhD; Heidi Zakoul, BA; Niklas Schmedt, DrPH; Lisette Koeneman, MD; Deborah J.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →